Table 1.
Demographic and Clinical Characteristics of Study Sample and Clusters
| Overall (n = 135) | Less-recurrent/severe (n = 73) | Chronic/recurrent (n = 62) | |
|---|---|---|---|
| M (SD) | M (SD) | M (SD) | |
| Age** | 38.71 (11.82) | 32.04 (9.87) | 46.56 (8.58) |
| Age at Onset** | 20.70 (9.69) | 24.11 (9.93) | 16.69 (7.73) |
| Illness Duration** | 18.01 (12.62) | 7.93 (5.49) | 29.87 (7.07) |
| Depressive Severitya | 7.52 (2.35) | 7.36 (2.55) | 7.72 (2.10) |
| Manic Severityb | 1.18 (1.12) | 1.11 (1.21) | 1.27 (1.02) |
| Number of Sessions | 9.29 (10.35) | 7.97 (9.80) | 10.85 (10.84) |
| Global Functioning | 57.64 (9.41) | 58.07 (9.15) | 57.15 (9.76) |
| # Medical Co-morbidities | 2.21 (1.65) | 2.04 (1.55) | 2.42 (1.74) |
| # Psychiatric Co-morbidities | 1.85 (1.10) | 1.82 (1.12) | 1.88 (1.09) |
| # Anxiety Disordersc | 1.35 (1.35) | 1.27 (1.30) | 1.45 (1.42) |
| n (%) | n (%) | n (%) | |
|---|---|---|---|
| Female Sex* | 83 (62) | 51 (70) | 32 (52) |
| Education >1 yr college | 99 (73) | 54 (75) | 45 (74) |
| Married | 46 (34) | 24 (33) | 22 (36) |
| Diagnosis | |||
| Bipolar I | 84 (62) | 46 (63) | 38 (61) |
| Bipolar II | 51 (38) | 27 (37) | 24 (39) |
| Lifetime Anxiety Disorder | 91 (67) | 47 (64) | |
| Sleep Status (% normal)d | 54 (46) | 27 (43) | |
| Baseline Medications | |||
| Mood Stabilizers | 89 (66) | 45 (63) | 37 (59) |
| Antidepressants* | 73 (54) | 26 (36) | 36 (58) |
| Atypical Antipsychotics | 100 (74) | 21 (29) | 14 (23) |
| Anxiolytics | 35 (26) | 17 (24) | 18 (29) |
| Anticonvulsants | 77 (57) | 39 (53) | 38 (61) |
*
p < .05
**
p <.01
a
Depressive severity rated by the Clinical Monitoring Form (Sachs et al., 2002)
b
Manic severity rated by the Clinical Monitoring Form (Sachs et al., 2002)
c
Refers to total number of lifetime (current or past) anxiety disorders
d
Sleep status refers to being a short (<6 hours/night), normal (6 – 8 hours/night), or long (>8 hours/night) sleeper in the week prior to the baseline visit
Please see page 9 for a full description of statistics